SCHEMBL31678874

SCHEMBL31678874

[2H]c1cc(NS(=O)(=O)C2CC2)ccn1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ PRMT6 Q96LA8 4/20 0.40
▸ SGK1 O00141 1/20 0.40
▸ CKS1B P61024 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ MAP2K4 P45985 1/20 0.39
▸ CYP17A1 P05093 2/20 0.37
▸ CTPS1 P17812 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ BRPF1 P55201 1/20 0.37
▸ JAK2 O60674 1/20 0.36
▸ PRMT1 Q99873 1/20 0.36
▸ PRMT8 Q9NR22 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ NAMPT P43490 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31678785 0.88 PTGS1 (0.53) PTGS1PTGS2PRMT6SGK1CKS1B
SCHEMBL30862914 0.72 ALDH1A1 (0.41) PTGS1PTGS2SGK1CKS1BSKP2
SCHEMBL6850398 0.72 HDAC4 (0.56) PTGS1PTGS2SGK1CKS1BSKP2
SCHEMBL31678837 0.72 PTGS1 (0.43) PTGS1PTGS2PRMT6CKS1BSKP2
SCHEMBL1099375 0.69 HDAC4 (0.47) PTGS1PTGS2PRMT6SGK1HDAC4
SCHEMBL21590270 0.69 CA1 (0.53) SGK1HDAC4MAP2K4TDP1BRPF1
SCHEMBL3980159 0.69 CA1 (0.53) SGK1HDAC4MAP2K4BRPF1JAK2
SCHEMBL3088517 0.69 SGK1 (0.51) PRMT6SGK1HDAC4MAP2K4BRPF1
SCHEMBL28207342 0.69 HDAC4 (0.47) PTGS1PTGS2PRMT6SGK1HDAC4
SCHEMBL14830078 0.69 MAP2K4 (0.56) SGK1HDAC4MAP2K4BRPF1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270200-A1 CTPS1 INHIBITORS AND USES THEREOF NIMBUS DISCOVERY, INC. 2025-08-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270200-A1 CTPS1 INHIBITORS AND USES THEREOF CTPS1, CTPS2, ECHS1 PTGS1 1724/4885PTGS2 2086/4885PRMT6 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback